Infographic: ranibizumab or bevacizumab treat & extend for neovascular age-related macular degeneration (AMD): LUCAS trial

被引：0
|
作者：
Barai, Ishani [1 ]
Sivaprasad, Sobha [1 ]
Henein, Christin [1 ]
机构：
[1] UCL, Inst Ophthalmol, London, England
来源：
EYE | 2025年 / 39卷 / SUPPL1期
关键词：
D O I：
10.1038/s41433-024-03339-z
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：129 / 131
页数：3
相关论文
共 50 条
  • [41] BEVACIZUMAB VERSUS RANIBIZUMAB FOR AGE-RELATED MACULAR DEGENERATION (AMD): A BUDGET IMPACT ANALYSIS
    Zimmermann, I
    Schneiders, R. E.
    Mosca, M.
    Alexandre, R. F.
    do Nascimento Jr, J. M.
    Gadelha, C. A.
    VALUE IN HEALTH, 2012, 15 (07) : A569 - A569
  • [42] Ocular and systemic safety of bevacizumab and ranibizumab in patients with neovascular age-related macular degeneration
    Johnson, Davin
    Sharma, Sanjay
    CURRENT OPINION IN OPHTHALMOLOGY, 2013, 24 (03) : 205 - 212
  • [43] Mental Status and Feasibility of an Intravitreal Ranibizumab Treat-and-Extend Regimen in Patients with Neovascular Age-Related Macular Degeneration
    Kato, Aki
    Yasukawa, Tsutomu
    Sugita, Iichiro
    Yoshida, Munenori
    Nozaki, Miho
    Hirano, Yoshio
    Kondo, Junko
    Abe, Tomohiro
    Sugita, Kimiko
    Okita, Takahide
    Morita, Hiroshi
    Takase, Noriaki
    Ogura, Yuichiro
    ADVANCES IN THERAPY, 2022, 39 (03) : 1403 - 1416
  • [44] INJECTION FREQUENCY AND PROGNOSTIC FACTORS IN A TREAT-AND-EXTEND REGIMEN OF INTRAVITREAL RANIBIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Narayan, Daniel
    Muecke, James
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 : 106 - 106
  • [45] Infographic: Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: the ANCHOR study
    Yusuf, Imran H.
    Henein, Christin
    Sivaprasad, Sobha
    EYE, 2024, 38 (SUPPL 2) : 39 - 40
  • [46] Ranibizumab versus bevacizumab for neovascular age-related macular degeneration: Results from the GEFAL noninferiority randomized trial
    Kodjikian, L.
    Souied, E. H.
    Mimoun, G.
    Decullier, E.
    Huot, L.
    Aulagner, G.
    ACTA OPHTHALMOLOGICA, 2013, 91
  • [47] Treat and extend compared to pro re nata in neovascular age-related macular degeneration
    Garreton, Rodolfo
    Gonzalez, Raul
    MEDWAVE, 2020, 20 (08):
  • [48] Ranibizumab versus Bevacizumab for Neovascular Age-related Macular Degeneration: Results from the GEFAL Noninferiority Randomized Trial
    Kodjikian, Laurent
    Souied, Eric H.
    Mimoun, Gerard
    Mauget-Faysse, Martine
    Behar-Cohen, Francine
    Decullier, Evelyne
    Huot, Laure
    Aulagner, Gilles
    OPHTHALMOLOGY, 2013, 120 (11) : 2300 - 2309
  • [49] Recurrence of neovascular age-related macular degeneration after cessation of treat and extend regimen
    Hirata, Yuki
    Oishi, Akio
    Maekawa, Yuki
    Tsuiki, Eiko
    Machida, Akira
    Kurihara, Junko
    Kitaoka, Takashi
    SCIENTIFIC REPORTS, 2022, 12 (01) : 14768
  • [50] Recurrence of neovascular age-related macular degeneration after cessation of treat and extend regimen
    Yuki Hirata
    Akio Oishi
    Yuki Maekawa
    Eiko Tsuiki
    Akira Machida
    Junko Kurihara
    Takashi Kitaoka
    Scientific Reports, 12
12345